Perrigo Co. PLC PRGO

What this company does

Perrigo offers products across categories including upper respiratory, nutrition, digestive health, pain and sleep-aids, oral care, healthy lifestyle, skin care, women's health, and vitamins, minerals and supplements. As of December 31, 2025, its global workforce consisted of approximately 8,100 full-time and part-time employees spread across 31 countries, of which approximately 17.5% were covered by collective agreements. Its primary manufacturing facilities are in the U.S., with additional manufacturing facilities in the U.K., Belgium, France, Germany and China, along with a joint venture in China. Its reporting and operating segments are Consumer Self-Care Americas, comprising its consumer self-care business in the U.S. and Canada, and Consumer Self-Care International, comprising its consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia. The CSCA segment develops, manufactures and markets self-care consumer solutions in the U.S. and Canada. Its branded products sold within that segment include Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid 24HR, REACH, Rembrandt, Steripod and Opill. The CSCI segment comprises consumer self-care product categories outside the U.S. and Canada, primarily branded products in Europe and Australia and store brand products in the United Kingdom and parts of Europe and Asia. Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013, and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013, in connection with the acquisition of Elan Corporation, plc.

Written from the business description in PERRIGO Co plc's annual report to the U.S. Securities and Exchange Commission, filed 26 February 2026. Every sentence was checked against that document before publication.